440

Compound name
Midostaurin
Alt Name
PKC412
Cgp 41251
PKC-412
Compound Image
Midostaurin.png
SMILES
CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC
MW
570.60
Brutto
C35H30N4O4
InChI
InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1
InChI Key
BMGQWWVMWDBQGC-IIFHNQTCSA-N
Approval Jurisdiction
2017 FDA 2017 EMA
Approved for clinical use
Acute Myeloid Leukemia (FLT3 Mutation-Positive)
CAS
120685-11-2
PubChem CID
9829523
Action
PKC; FLT3
Approved Drug List
1
Commercial Vendor
Novartis